25.6.19
This website uses cookies to ensure you get the best experience on our website. Learn more

Introduction to Ketamine

2 Credentials
This bundle includes two courses: Introduction to Ketamine for Mental Health and Introduction to Ketamine-assisted Therapy. These courses feature Fluence Trainers Dr. Ingmar Gorman, Dr. Elizabeth Nielson, Jeffrey Guss, MD, and Casey Paleos, MD. Between them, these researchers and clinicians have extensive experience in clinical trials of psychedelic-assisted therapy and private practice KAP, clinical work in preparation and integration of ketamine experiences, and training clinicians in psychedelic therapy–both for research trials and private practice settings.
Viewing 1-2 of 2

Introduction to Ketamine for Mental Health

The course features Fluence Trainer Casey Paleos, MD and covers mechanisms of action, emerging indications, treatment models, subjective effects, and risks and precautions.

Learning Objectives

At the end of this program, participants will be able to:

  • Describe the current clinical research on ketamine’s safety, efficacy, clinical indications, and contraindications.

  • List current evidence-based practices for use of set and setting to optimize safe, effective, and ethical ketamine administration and dosing.

Skills
  • Evidence-Based Practice
  • Ketamine Clinical Applications
  • Ketamine Safety

Introduction to Ketamine-Assisted Therapy

Introduction to Ketamine-Assisted Therapy covers the theoretical background, orientation, and practical knowledge for conducting ketamine-assisted psychotherapy, and includes four demonstration session recordings.

Learning Objectives

At the end of this program, Participants will be able to:

  • Describe the current clinical research on ketamine’s safety, efficacy, clinical indications, and contraindications.

  • List current evidence-based practices for use of set and setting to optimize safe, effective, and ethical ketamine administration and dosing.

  • Analyze factors of ‘set and setting’ as they relate to a) physical features of a dosing environment; b) therapist gender identity; c) the role of race, culture, and ethnicity; and d) early sexual, physical, and/or emotional abuse histories.

  • List current evidence-based practices for use of therapeutic ketamine to optimize safe, effective, and ethical ketamine administration and dosing.

  • Prepare a plan to help patients navigate a range of treatment outcomes, including those related to disappointment and/or sudden wellness.

Skills
  • Ketamine Safety
  • Set and Setting in Psychedelic Therapy
  • Ketamine Clinical Research
Viewing 1-2 of 2